Related Experiment Video
Updated: Oct 12, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Physician Diagnosis and Knowledge of Mild Cognitive Impairment
Emilie M Blair1, Darin B Zahuranec1,2, Jane Forman1,3
1Department of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor, MI, USA.
Background:
Older adults with mild cognitive impairment (MCI) receive fewer guideline-concordant treatments for multiple health conditions than those with normal cognition. Reasons for this disparity are unclear.
Objective:
To better understand this disparity, we describe physician understanding and experience with patient MCI, particularly physician identification of MCI, ability to distinguish between MCI and dementia, and perspectives on education and training in MCI and dementia.
Methods:
As part of a mixed-methods study assessing the influence of patient MCI on physician recommendations for acute myocardial infraction and stroke treatments, we conducted a descriptive qualitative study using semi-structured interviews of physicians from three specialties. Key question topics included participants' identification of MCI, impressions of MCI and dementia awareness within their practice specialty, and perspectives on training and education in MCI.
Results:
The study included 22 physicians (8 cardiologists, 7 neurologists, and 7 internists). We identified two primary themes: There is 1) a lack of adequate understanding of the distinction between MCI and dementia; and 2) variation in physician approaches to identifying whether an older adult has MCI.
Conclusion:
These findings suggest that physicians have a poor understanding of MCI. Our results suggest that interventions that improve physician knowledge of MCI are needed.
Insights
Physicians show a poor understanding of mild cognitive impairment (MCI), struggling to distinguish it from dementia. This knowledge gap impacts treatment decisions for older adults, highlighting a need for improved physician education on MCI.
Area of Science:
- Gerontology
- Neurology
- Internal Medicine
Background:
- Older adults with mild cognitive impairment (MCI) receive suboptimal guideline-concordant treatments compared to those with normal cognition.
- The reasons behind this treatment disparity in older adults with MCI remain largely unexplained.
Purpose of the Study:
- To investigate physician understanding and experience with mild cognitive impairment (MCI) in older adults.
- To assess physician identification of MCI, differentiation from dementia, and perspectives on relevant education and training.
Main Methods:
- A descriptive qualitative study utilizing semi-structured interviews with 22 physicians (cardiologists, neurologists, internists).
- The study assessed physician identification of MCI and awareness of MCI/dementia within their specialties.
Main Results:
- Physicians demonstrated a lack of adequate understanding distinguishing MCI from dementia.
- Significant variation exists in how physicians identify MCI in older adult patients.
- Physicians reported varying approaches to identifying MCI in clinical practice.
Conclusions:
- Physician understanding of MCI is inadequate, impacting clinical practice.
- Interventions are necessary to enhance physician knowledge and diagnostic skills regarding MCI.
- Improved physician education on MCI is crucial for equitable treatment of older adults.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Development During Adulthood
Alzheimer's Disease: Treatment
Intellectual Disability